Quarterly report [Sections 13 or 15(d)]

Net Income (Loss) Per Share - Schedule of Outstanding Shares of Potentially Dilutive Securities (Details)

v3.25.3
Net Income (Loss) Per Share - Schedule of Outstanding Shares of Potentially Dilutive Securities (Details) - shares
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Schedule of Outstanding Shares of Potentially Dilutive Securities [Line Items]        
Antidilutive Securities 18,796,272 20,999,327 18,796,272 20,999,327
Options to purchase common stock [Member]        
Schedule of Outstanding Shares of Potentially Dilutive Securities [Line Items]        
Antidilutive Securities 2,033,114 1,367,114 2,033,114 1,367,114
Warrants to purchase common stock [Member]        
Schedule of Outstanding Shares of Potentially Dilutive Securities [Line Items]        
Antidilutive Securities 478,419 478,419 478,419 478,419
Restricted Stock Units [Member]        
Schedule of Outstanding Shares of Potentially Dilutive Securities [Line Items]        
Antidilutive Securities 3,677 2,177 3,677 2,177
Common stock issuable upon conversion of Series B-1 convertible preferred stock [Member]        
Schedule of Outstanding Shares of Potentially Dilutive Securities [Line Items]        
Antidilutive Securities 788,200 788,200
Common stock issuable upon conversion of Series A-2 Prime convertible preferred stock [Member]        
Schedule of Outstanding Shares of Potentially Dilutive Securities [Line Items]        
Antidilutive Securities 462,245 2,267,600 462,245 2,267,600
Warrants to purchase convertible preferred stock [Member]        
Schedule of Outstanding Shares of Potentially Dilutive Securities [Line Items]        
Antidilutive Securities 15,818,817 16,095,817 15,818,817 16,095,817